Tech Company Financing Transactions
Cardea Bio Funding Round
Cardea Bio secured a $7.5 million Series A funding round on 9/18/2020. Backers included Agilent Technologies, Foothill Ventures and Lifespan Investments.
Transaction Overview
Company Name
Announced On
9/18/2020
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Series A
Investors
Proceeds Purpose
The capital will help accelerate the growth and development of the Company's proprietary Tech+Bio Infrastructure and chipsets that enable Cardea's Innovation Partners to bring Powered by Cardea products to market with features and competitive advantages never seen before.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8969 Kenamar Dr. 104
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cardea is the world's leading manufacturer and developer of breakthrough digital graphene biosensors that power the Internet of Biology. Cardea's mission is to transform the healthcare industry with innovative new capabilities that enable superior pharmaceutical development and monitoring, rapid onsite diagnostics, and cutting-edge life science research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Heltzen
Chief Operating Officer
Janine Taylor
Chief Scientific Officer
Kiana Aran
Chief Technical Officer
Brett Goldsmith
VP - Bus. Development
Robert Lozuk
VP - Product Management
Ross Bundy
Browse more venture capital transactions:
Prev: 9/18/2020: Lava Therapeutics venture capital transaction
Next: 9/18/2020: Finch Therapeutics venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs